Behera Kishore Kumar, Saharia Gautom Kumar, Hota Debasish, Sahoo Durgesh Prasad, Sethy Madhusmita, Srinivasan Anand
Department of Endocrinology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Department of Biochemistry, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Niger Med J. 2020 Sep-Oct;61(5):237-240. doi: 10.4103/nmj.NMJ_200_20. Epub 2020 Oct 13.
Hashimoto's thyroiditis (HT) is a variant of autoimmune thyroid disorders (AITD) which has been associated with vitamin D (vit-D) deficiency. However, whether vit-D supplementation is linked to reduction of thyroid autoantibodies and improvement of thyroid function is not well characterized. The present study was planned to evaluate the effect of vit-D supplementation on possible improvement of thyroid autoantibody titer and thyroid hormone profile in patients with AITD subjects.
Twenty-three patients of HT were given weekly supplementation of 60,000 IU vit-D for 8 weeks followed by once a month for another 4 months. After 6 months of vit-D supplementation, thyroid autoantibody titer (TPO antibody) and thyroid hormone profile was rechecked.
Mean serum vit-D was increased significantly from 15.33 ± 5.71 to 41.22 ± 12.24 ng/mL (normal levels) after supplementation. There was significant increase in thyroid autoantibody titre (from 746.8 ± 332.2 to 954.1 ±4 59.8 IU/ml; = 0.006) and TSH level (7.23 ± 3.16 to 3.04 ± 2.62 (mIU/L); = 0.01) following 6 months of vit-D supplementation.
Vitamin-D levels were low in AITD patients in eastern India and, its supplementation in HT patients increased thyroid antibody titer and there was significant reduction in serum TSH and increased in free T4.
桥本甲状腺炎(HT)是自身免疫性甲状腺疾病(AITD)的一种变体,与维生素D(vit-D)缺乏有关。然而,补充vit-D是否与甲状腺自身抗体的降低和甲状腺功能的改善相关,目前尚不明确。本研究旨在评估补充vit-D对AITD患者甲状腺自身抗体滴度和甲状腺激素水平可能的改善作用。
23例HT患者每周补充60,000 IU vit-D,持续8周,之后每月补充一次,再持续4个月。补充vit-D 6个月后,复查甲状腺自身抗体滴度(TPO抗体)和甲状腺激素水平。
补充后血清vit-D平均水平从15.33±5.71显著升高至41.22±12.24 ng/mL(正常水平)。补充vit-D 6个月后,甲状腺自身抗体滴度(从746.8±332.2升至954.1±459.8 IU/ml;P = 0.006)和TSH水平(从7.23±3.16升至3.04±2.62(mIU/L);P = 0.01)均显著升高。
印度东部AITD患者的维生素D水平较低,补充vit-D可使HT患者的甲状腺抗体滴度升高,血清TSH显著降低,游离T4升高。